Sms Pharmaceuticals Q1 Results
- BSE: 532815
- NSE: SMSPHARMA
- ISIN: INE812G01025
- Sector: Biotechnology & Drugs
BSE
190.30
0.00 (0.00%)
0.00 (0.00%)Volume11.27 K
Updated: Thu 13 Mar, 2025 | 15:55:53
NSE
190.86
0.88 (0.46%)
0.88 (0.46%)Volume43.41 K
Updated: Thu 13 Mar, 2025 | 15:56:40
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Sms Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 24 | QoQ Comp | Jun 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 164.45 | 245.80 | -33.10% | 135.34 | 21.51% |
| Selling/ General/ Admin Expenses Total | 16.88 | 22.93 | -26.38% | 13.55 | 24.57% |
| Depreciation/ Amortization | 8.38 | 7.92 | 5.88% | 7.69 | 8.98% |
| Other Operating Expenses Total | 7.90 | 6.70 | 17.90% | 7.72 | 2.26% |
| Total Operating Expense | 139.32 | 220.10 | -36.70% | 116.85 | 19.23% |
| Operating Income | 25.13 | 25.70 | -2.22% | 18.49 | 35.89% |
| Net Income Before Taxes | 21.83 | 21.74 | 0.43% | 12.68 | 72.13% |
| Net Income | 16.48 | 17.28 | -4.63% | 9.34 | 76.41% |
| Diluted Normalized EPS | 1.95 | 2.05 | -4.83% | 1.10 | 77.27% |